Skip to main content
Sopharma AD logo

Sopharma AD — Investor Relations & Filings

Ticker · SFA ISIN · BG11SOSOBT18 LEI · 097900BGGW0000048796 BSOBGN Manufacturing
Open in API
Filings indexed 1,482 across all filing types
Latest filing 2023-09-20 Director's Dealing
Country BG Bulgaria
Listing BSOBGN SFA

About Sopharma AD

https://www.sopharmagroup.com/

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Recent filings

Filing Released Lang Actions
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 19 September 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains the header: "Current report: №144/ 20.09.2023 NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". This clearly indicates a report detailing transactions by persons discharging managerial responsibilities (insiders) or persons closely associated with them. This aligns perfectly with the definition for Director's Dealing (DIRS), which covers reports of personal share transactions by directors and executives (insider trades). The structure detailing the person, position, issuer, and specific transaction details (sell, price, volume) confirms this classification.
2023-09-20 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 19 September 2023.
Director's Dealing Classification · 100% confidence The document text explicitly contains the header "NOTIFICATION OF INSIDERS' TRANSACTIONS under art. 19 of Regulation 596/2014". It details transactions made by a 'person discharging managerial responsibilities' or a 'person closely associated' (Donev Investments Holding AD, associated with Ognian Donev) involving the issuer's financial instruments (Warrants). This structure and content are characteristic of mandatory regulatory filings disclosing insider trading activity, which corresponds to the Director's Dealing category.
2023-09-20 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 19 September 2023.
Director's Dealing Classification · 100% confidence The document details a transaction involving a person discharging managerial responsibilities (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD). Specifically, it reports the 'Sell' of financial instruments (Warrants) on a specific date (19.9.2023) with associated prices and volumes. This structure—reporting personal share transactions by directors/executives—perfectly matches the definition of Director's Dealing.
2023-09-20 English
Notification from Ognian Donev under Art. 19 of Regulation (EU) No 596/2014 of 19 September 2023.
Director's Dealing Classification · 100% confidence The document details a transaction involving a 'person discharging managerial responsibilities' (Ognian Donev, Executive director and chairman of the Board of directors of Sopharma AD). It specifies the nature of the transaction ('Buy'), the financial instrument ('Warrants'), and the price/volume details. This structure is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2023-09-20 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 18 September 2023.
Director's Dealing Classification · 100% confidence The document text contains structured tables detailing a transaction involving a 'person discharging managerial responsibilities' or a 'person closely associated' (Donev Investments Holding AD, associated with Ognian Donev of Sopharma AD). It specifies the nature of the transaction ('Buy'), the financial instrument (Warrants), the price, and the volume. This format and content are characteristic of mandatory regulatory filings reporting insider transactions, specifically director's dealing or transactions by persons closely associated with management, as mandated by regulations like MAR (Regulation 596/2014 mentioned in the text). This directly corresponds to the definition of Director's Dealing (DIRS).
2023-09-19 English
Notification from "Donev investments holding" AD under Art. 19 of Regulation (EU) No 596/2014 of 18 September 2023.
Director's Dealing Classification · 100% confidence The document text details a transaction involving a 'person discharging managerial responsibilities/person closely associated' (Donev Investments Holding AD) concerning shares of 'Sopharma AD'. It specifies the nature of the transaction as 'Buy' and lists the price(s) and volume(s) of the shares traded. This structure is characteristic of mandatory insider trading disclosures, specifically reporting personal share transactions by company directors and executives. This aligns directly with the definition for Director's Dealing (DIRS).
2023-09-19 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.